Publications by authors named "Philip Mack"

Claim this Profile
C
Corrigendum to "The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database. [Journal of Thoracic Oncology Vol. 20 No. 10: 1423-1440]".
David P Carbone, Fred R Hirsch, Raymond Uyiosa Osarogiagbon, Katherine K Nishimura, Ming Sound Tsao, Philip C Mack

J Thorac Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database.
David P Carbone, Fred R Hirsch, Raymond Uyiosa Osarogiagbon, Katherine K Nishimura, Ming Sound Tsao, Philip C Mack

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In the time of COVID-19: challenges, successes, and lessons learned from studies in cancer patients.
Philip C Mack, James M Crawford, Andres Chang, Anna Yin, Sabra L Klein

J Natl Cancer Inst· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study.
Philip C Mack, Mary W Redman, Hanna Tukachinsky, David E Kozono, Katherine Minichiello

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of Lung Cancer in Egypt: Moving Towards Improved Guidelines for Prevention, Screening, Treatment, and Clinical Care Programs.
Nagla Abdel Karim, Ahmed Magdy Rabea, Philip C Mack, Janakiraman Subramanian, Ehab Khalil

JTO Clin Res Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400).
David Kozono, Xing Hua, Michael C Wu, Khaled A Tolba, Saiama N Waqar, Philip C Mack

J Thorac Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed SARS-CoV-2 Infections.
Medha Somisetty, Philip C Mack, Chih-Yuan Hsu, Yuanhui Huang, Jorge E Gomez

Clin Lung Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC.
Philip C Mack, Rachel B Keller-Evans, Gerald Li, Katherine T Lofgren, Alexa B Schrock

Oncologist· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer.
Philip C Mack, Chih-Yuan Hsu, Ananda M Rodilla, Jorge E Gomez, Jazz Cagan

Vaccines (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-cancer early detection (MCED) tests: prioritizing equity from bench to bedside.
Sarah J Miller, Jamilia R Sly, Christian Rolfo, Philip Mack, Augusto Villanueva

Health Aff Sch· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers.
Douglas I Lin, Richard S P Huang, Ioannis Ladas, Rachel B Keller, Nimesh R Patel, Philip C Mack

Front Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer.
Aakash Desai, Tadana A Vázquez, Keishla M Arce, Marcelo Corassa, Philip C Mack

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer.
Ananda M Rodilla, Rajesh M Valanparambil, Philip C Mack, Chih-Yuan Hsu, Jazz Cagan

Cancer Cell· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042).
Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, James Moon, Philip C Mack

Clin Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Capability of PD-L1 Protein Expression for Patients With Advanced NSCLC: Any Differences Based on Histology?
Noy Meshulami, Sooyun Tavolacci, Diego de Miguel-Perez, Christian Rolfo, Philip C Mack

Clin Lung Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer Patients: Short Review.
Ananda M Rodilla, Sooyun Tavolacci, Jazz Cagan, Tanay Shah, Sandeep Mittan, Philip C Mack

Vaccines (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer.
Diego de Miguel-Perez, Alessandro Russo, Muthukumar Gunasekaran, Francesco Buemi, Lisa Hester, Philip C Mack

Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Analyses of COVID-19 Vaccination in Patients With Lung Cancer: Antibody Responses and Variant-Specific Neutralization.
Philip C Mack, Fred R Hirsch, Paul A Bunn, John D Minna

J Clin Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non-Small Cell Lung Cancer.
Xing Yi Woo, Anuj Srivastava, Philip C Mack, Joel H Graber, Brian J Sanderson

Cancer Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving role of liquid biopsy in lung cancer.
Umberto Malapelle, Pasquale Pisapia, Francesco Pepe, Gianluca Russo, Mauro Buono, Philip C Mack

Lung Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403).
Philip C Mack, Jieling Miao, Mary W Redman, James Moon, Sarah B Goldberg

Clin Cancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.
Justin A Chen, Jasmine C Huynh, Chun-Yi Wu, Ai-Ming Yu, Karen Matsukuma, Philip C Mack

Cancer Chemother Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.
Philip C Mack, Michael I Klein, Kristin L Ayers, Xiang Zhou, Sunny Guin

Oncologist· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer.
Philip C Mack, Jorge E Gomez, Ananda M Rodilla, Juan Manuel Carreño, Chih-Yuan Hsu

Cancer Cell· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer.
Diego de Miguel-Perez, Alessandro Russo, Oscar Arrieta, Murat Ak, Feliciano Barron, Philip C Mack

J Exp Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis